Association of the apolipoproteins with retinal arteriosclerosis in a health examination population

• by Xinghe Sun, Lijuan Guo, Hui Lv, Xian Zhang, Chaoqun Wu, Xiaohui Liu

• June 17, 2026

Retinal and choroidal vascular density alterations in patients with schizophrenia: assessment via optical coherence tomography angiography

• by Jun Liu, Guangyuan Wang, Hui Zhang, Suqi Song, Kai Zhang, Ruimei Ni, Le Ren, Yayun Xu, Dachuan Zhang, Yong Wang, Zhengxuan Jiang

• January 31, 2026

GLP-1 Eye Effects Raise Questions

Authors describe both potential retinal benefits and possible rare optic nerve risks, while emphasizing that long-term ocular safety data remain limited as use expands.

• by Kerri Miller

• March 24, 2026

• 2 min

FDA Monthly Preview: Key May Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• April 29, 2026

• 4 min